6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity. [PDF]
Wang L +10 more
europepmc +1 more source
Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H. [PDF]
Kankanala J +6 more
europepmc +1 more source
Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex That Confer Multinucleoside Drug Resistance. [PDF]
Das K, Martinez SE, Arnold E.
europepmc +1 more source
Data on synthesis of methylene bisphosphonates and screening of their inhibitory activity towards HIV reverse transcriptase. [PDF]
Yanvarev DV +7 more
europepmc +1 more source
M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA. [PDF]
Oliveira M +5 more
europepmc +1 more source
Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H. [PDF]
Kankanala J +8 more
europepmc +1 more source
Genetic diversity and drug resistance mutations of HIV-1 in Ghana: a systematic review of two decades. [PDF]
Appiah P +12 more
europepmc +1 more source
Enzyme Selectivity of HIV Reverse Transcriptase: Conformations, Ligands, and Free Energy Partition. [PDF]
Kirmizialtin S, Johnson KA, Elber R.
europepmc +1 more source
HIV-1 drug resistance and associated risk factors in patients with antiretroviral therapy failure in Chongqing, China, 2019-2023. [PDF]
Zhang H, Wu P, Ye W.
europepmc +1 more source
Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunity. [PDF]
Washaya T +6 more
europepmc +1 more source

